Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. med. biol. res ; 48(10): 863-870, Oct. 2015. tab, ilus
Artículo en Inglés | LILACS | ID: lil-761606

RESUMEN

We aimed to investigate the effects of an anti-tumor necrosis factor-α antibody (ATNF) on cartilage and subchondral bone in a rat model of osteoarthritis. Twenty-four rats were randomly divided into three groups: sham-operated group (n=8); anterior cruciate ligament transection (ACLT)+normal saline (NS) group (n=8); and ACLT+ATNF group (n=8). The rats in the ACLT+ATNF group received subcutaneous injections of ATNF (20 μg/kg) for 12 weeks, while those in the ACLT+NS group received NS at the same dose for 12 weeks. All rats were euthanized at 12 weeks after surgery and specimens from the affected knees were harvested. Hematoxylin and eosin staining, Masson's trichrome staining, and Mankin score assessment were carried out to evaluate the cartilage status and cartilage matrix degradation. Matrix metalloproteinase (MMP)-13 immunohistochemistry was performed to assess the cartilage molecular metabolism. Bone histomorphometry was used to observe the subchondral trabecular microstructure. Compared with the rats in the ACLT+NS group, histological and Mankin score analyses showed that ATNF treatment reduced the severity of the cartilage lesions and led to a lower Mankin score. Immunohistochemical and histomorphometric analyses revealed that ATNF treatment reduced the ACLT-induced destruction of the subchondral trabecular microstructure, and decreased MMP-13 expression. ATNF treatment may delay degradation of the extracellular matrix via a decrease in MMP-13 expression. ATNF treatment probably protects articular cartilage by improving the structure of the subchondral bone and reducing the degradation of the cartilage matrix.


Asunto(s)
Animales , Femenino , Adalimumab/farmacología , Antirreumáticos/farmacología , Huesos/efectos de los fármacos , Cartílago Articular/efectos de los fármacos , Osteoartritis/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Artroplastia Subcondral , Ligamento Cruzado Anterior/cirugía , Artritis Experimental/tratamiento farmacológico , Huesos/metabolismo , Cartílago Articular/metabolismo , Matriz Extracelular/efectos de los fármacos , Miembro Posterior/patología , Miembro Posterior/cirugía , Inmunohistoquímica , Puntaje de Gravedad del Traumatismo , /efectos de los fármacos , /metabolismo , Osteoartritis/cirugía , Factores Protectores , Distribución Aleatoria , Ratas Sprague-Dawley
2.
Southeast Asian J Trop Med Public Health ; 1975 Jun; 6(2): 170-4
Artículo en Inglés | IMSEAR | ID: sea-30563

RESUMEN

Toxoplasma gondii antibody titers as determined by either the indirect hemagglutination test or the methylene blue dye test were determined for a group of aborigines and for Chinese as well as for swine, cats, rats, dogs and one bovine, all resident on the island of Taiwan. None of the 194 aborigines and only 3 (1.97%) of the 152 Chinese were found to be positive. Of 433 swine tested 132 (30.5%) were positive. Thirteen (27.7%) of 47 domestic pet cats were positive while none of 11 feral cats were positive. None of the 29 rats, 3 dogs or the one bovine were positive. Possible reasons for the lack of infection in Chinese is discussed.


Asunto(s)
Animales , Anticuerpos/aislamiento & purificación , Enfermedades de los Gatos/parasitología , Gatos , Bovinos , Enfermedades de los Bovinos/parasitología , Enfermedades de los Perros/parasitología , Perros , Microbiología de Alimentos , Humanos , Ratas , Pruebas Serológicas/métodos , Porcinos , Enfermedades de los Porcinos/parasitología , Taiwán , Toxoplasma/aislamiento & purificación , Toxoplasmosis/epidemiología , Toxoplasmosis Animal/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA